“I might advise pregnant girls to soak up as little caffeine as doable and swap to decaf altogether if they’ll,” Foxe mentioned.
However he urged girls to not go chilly turkey in the event that they might help it, as a result of caffeine withdrawal could cause a number of signs, together with complications, irritability, nausea and issue concentrating.
“We do not know what withdrawal, irritability, stress and nervousness will do to a being pregnant,” Foxe mentioned. “Attempt to whittle away at your caffeine consumption earlier than you get pregnant.”
The examine does have some limitations. Ladies had been requested to recall how a lot caffeine they consumed whereas pregnant, and reminiscence is not at all times 100% correct.
The findings had been just lately revealed on-line within the journal Neuropharmacology.
Dr. Mark Klebanoff, principal investigator on the Middle for Perinatal Analysis in Columbus, Ohio, mentioned many research have seemed on the results of caffeine on being pregnant outcomes, akin to danger of miscarriage. However much less is thought about how caffeine impacts children as they age.
“The brand new examine provides to the literature, however it’s not sufficient to essentially implicate caffeine in any robust means,” mentioned Klebanoff, who was not concerned with the examine however reviewed the findings.
“Pregnant girls could be fairly reassured that consuming lower than 200 milligrams per day of caffeine won’t trigger miscarriage or preterm beginning,” he mentioned. However extra examine is required on the way it impacts baby growth, Klebanoff added.
“A typical cup at residence has about 100 mg of caffeine, so girls can restrict themselves to 2 cups a day when pregnant,” he mentioned.
However they need to remember that different sources of caffeine (akin to power drinks, energy bars and chocolate) ought to be thought-about as a part of the full, Klebanoff mentioned.
The American School of Obstetricians and Gynecologists gives recommendation on espresso and caffeine during pregnancy.
SOURCES: John Foxe, PhD, director, Del Monte Institute for Neuroscience, College of Rochester, Rochester, N.Y.; Mark Klebanoff, MD, principal investigator, Middle for Perinatal Analysis, Abigail Wexner Analysis Institute, Nationwide Kids’s Hospital, Columbus, Ohio; Neuropharmacology, Jan. 30, 2021, on-line